Among 60 genes selected for targeted sequencing, amplifications of the CCND1 and ERBB2 genes were detected in both ctDNA and the primary cancer (Fig. 4A and Supplementary Figure S7) in this patient. This evidence concerns the gene CCND1 and cancer.